Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armand Keating

Showing results (171-180 of 186) with videos related to

Pageof 19
Sort By:
Molecular Therapy. Methods & Clinical Development|June 13, 2017
Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34<sup>+</sup> Cells for Correction of Fabry DiseaseJu Huang, Aneal Khan, Bryan C Au, et al.
Nature Communications|February 26, 2021
Lentivirus-mediated gene therapy for Fabry diseaseAneal Khan, Dwayne L Barber, Ju Huang, et al.
British Journal of Haematology|December 11, 2002
Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remissionMark R Litzow, Waleska S Pérez, John P Klein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplantSonali M Smith, Koen van Besien, Jeanette Carreras, et al.
Blood|December 25, 2009
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemiaMark R Litzow, Sergey Tarima, Waleska S Pérez, et al.
Blood|March 25, 2004
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcomeCorey S Cutler, Stephanie J Lee, Peter Greenberg, et al.
Blood|April 10, 2008
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remissionDavid I Marks, Waleska S Pérez, Wensheng He, et al.
Blood|July 12, 2019
Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemiaAntonio R Lucena-Araujo, Juan L Coelho-Silva, Diego A Pereira-Martins, et al.
Cancers|October 30, 2020
Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic LeukemiaIsabel Weinhäuser, Diego A Pereira-Martins, Cesar Ortiz, et al.
Blood|July 31, 2008
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemiaStephanie J Lee, Manisha Kukreja, Tao Wang, et al.
Pageof 19

Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Molecular Therapy. Methods & Clinical Development|June 13, 2017
Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34<sup>+</sup> Cells for Correction of Fabry DiseaseJu Huang, Aneal Khan, Bryan C Au, et al.
Nature Communications|February 26, 2021
Lentivirus-mediated gene therapy for Fabry diseaseAneal Khan, Dwayne L Barber, Ju Huang, et al.
British Journal of Haematology|December 11, 2002
Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remissionMark R Litzow, Waleska S Pérez, John P Klein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplantSonali M Smith, Koen van Besien, Jeanette Carreras, et al.
Blood|December 25, 2009
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemiaMark R Litzow, Sergey Tarima, Waleska S Pérez, et al.
Blood|March 25, 2004
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcomeCorey S Cutler, Stephanie J Lee, Peter Greenberg, et al.
Blood|April 10, 2008
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remissionDavid I Marks, Waleska S Pérez, Wensheng He, et al.
Blood|July 12, 2019
Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemiaAntonio R Lucena-Araujo, Juan L Coelho-Silva, Diego A Pereira-Martins, et al.
Cancers|October 30, 2020
Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic LeukemiaIsabel Weinhäuser, Diego A Pereira-Martins, Cesar Ortiz, et al.
Blood|July 31, 2008
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemiaStephanie J Lee, Manisha Kukreja, Tao Wang, et al.
Pageof 19